Tag: leukapheresis device market growth

Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.

#Leukapheresis Device Market Size Outlook: How Quickly Will Revenue Expand Through 2030?#_x000D_

The size of the leukapheresis device market has demonstrated robust growth recently. This market is forecast to expand from $0.7 billion in 2025 to $0.76 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.6%. Historically, this expansion can be ascribed to several factors, including the increasing prevalence of leukemia and autoimmune disorders, the wider adoption of stem cell therapies, significant advancements in blood cell separation technology, a rise in clinical research activities, and the expansion of hospital-based apheresis services._x000D_

_x000D_

The leukapheresis device market is anticipated to experience substantial expansion over the upcoming years. It is projected to reach $1.01 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 7.4%. Key factors driving this growth during the projected period include the increasing demand for portable leukapheresis systems, the incorporation of AI and automation into devices, the broadening scope of biopharmaceutical research, new regulatory approvals for sophisticated apheresis technologies, and increased investments in precision medicine. Prominent trends expected over the forecast horizon encompass individualized leukapheresis therapies, less invasive apheresis methods, portable and point-of-care leukapheresis equipment, the incorporation of real-time monitoring systems, and improvements in automation and operational efficiency._x000D_

_x000D_

#Get A Free Sample Report With In-Depth Market Insights:#_x000D_

https://thebusinessresearchcompany.com/sample_request?id=21548890&type=smp&name=Leukapheresis%20Device%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR_x000D_

_x000D_

#Leukapheresis Device Market Growth Drivers: What’s Behind The Acceleration?#_x000D_

The increasing occurrence of blood-related conditions is anticipated to drive the expansion of the leukapheresis device market in the future. These conditions impact the composition or operation of blood cells, leading to issues with oxygen transport, immune system function, or blood coagulation. The growing number of blood-related disorders is mainly due to an older demographic, as elderly individuals are more prone to ailments such as anemia, leukemia, and various hematological conditions. Leukapheresis equipment aids in managing these illnesses by precisely removing surplus or abnormal white blood cells from circulation, thereby helping to ease symptoms and lessen complications in diseases like leukemia and autoimmune conditions. For example, in March 2024, the Leukaemia Foundation, an Australia-based non-profit organization, reported that approximately 19,500 Australians received a diagnosis of blood cancer, including leukemia, lymphoma, and myeloma, with almost 43% incurring substantial out-of-pocket treatment expenses and 42% needing over three months away from work, underscoring both the increased frequency and the financial strain on patients and their relatives compared to prior years. Consequently, the escalating incidence of blood-related disorders is fueling the expansion of the leukapheresis device market._x000D_

_x000D_

#Leukapheresis Device Market Segment Analysis And Revenue Potential#_x000D_

The leukapheresis device market covered in this report is segmented – _x000D_

_x000D_

1) By Device Type: Therapeutic Leukapheresis, Cytapheresis, Stem Cell Collection, Research Applications, Leukapheresis Columns and Cell Separators, Leukapheresis Disposables, Apheresis Devices_x000D_

2) By Component: Leukapheresis Machine, Blood Collection Set , Medical Consumables , Filters_x000D_

3) By End User: Hospitals, Academic Research Institutes, Pharmaceutical And Biotechnology Companies, Blood Component Providers, Blood Centers_x000D_

_x000D_

Subsegments:_x000D_

1) By Therapeutic Leukapheresis: Leukemia Treatment Systems, Sepsis Treatment Leukapheresis Units, Autoimmune Disease Management Devices_x000D_

2) By Cytapheresis: Plateletpheresis Devices, Lymphapheresis Units, Erythrocytapheresis Systems_x000D_

3) By Stem Cell Collection: Peripheral Blood Stem Cell (PBSC) Collection Devices, Umbilical Cord Blood Collection Systems, Bone Marrow Stem Cell Apheresis Systems_x000D_

4) By Research Applications: Cell Separation Systems for Research and Development, Clinical Trial Apheresis Platforms, Academic Laboratory Leukapheresis Devices_x000D_

5) By Leukapheresis Columns And Cell Separators: Adsorption Columns, Membrane-Based Cell Separation Systems, Centrifugal Cell Separators_x000D_

6) By Leukapheresis Disposables: Tubing Sets, Needles And Catheters, Collection Bags_x000D_

7) By Apheresis Devices: Continuous Flow Apheresis Machines, Portable Or Mobile Apheresis Units, Intermittent Flow Apheresis Systems_x000D_

_x000D_

#Leukapheresis Device Market Trends: What’s Defining The Industry’s Next Phase?#_x000D_

Major companies in the leukapheresis device market are concentrating on funneling capital into regional production capabilities to boost local access to high-quality therapeutic devices and support national healthcare aims. Investments in regional manufacturing aid in establishing efficient and flexible supply chains, which ensure on-time delivery, lessen dependence on imports, and enhance the affordability of advanced blood and cell collection systems. For instance, in November 2024, Terumo Blood and Cell Technologies, a US-based medical technology company, partnered with Terumo Medical Products (Hangzhou) Co., Ltd., a China-based medical technology subsidiary company, to inaugurate localized production in Hangzhou, China. This strategic initiative involves the domestic manufacturing of key leukapheresis products, including the Trima Accel Automated Blood Collection System and the Spectra Optia Apheresis System, both extensively employed in China for therapeutic apheresis, stem cell collection, and blood component separation._x000D_

_x000D_

#Leukapheresis Device Market Competitive Overview And Top Companies#_x000D_

Major companies operating in the leukapheresis device market are Fresenius SE and Co. KGaA, Asahi Kasei Medical Co. Ltd, Baxter International Inc., Grifols S.A., TERUMO BCT INC., Kaneka Corporation, Nikkiso Co. Ltd, Haemonetics Corporation, Miltenyi Biotec GmbH, Macopharma, B. Braun Melsungen AG, Kawasumi Laboratories Inc., Beijing Zksk Technology Co. Ltd, Puriblood Medical Co. Ltd, Fresenius Kabi AG, JMS Co. Ltd, HemaCare Corporation, Medica Group PLC, LivaNova PLC, Cytiva, BioSafe Group SA, Terumo Corporation _x000D_

_x000D_

#View The Full Leukapheresis Device Market Report:#_x000D_

https://thebusinessresearchcompany.com/report/leukapheresis-device-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR_x000D_

_x000D_

#Leukapheresis Device Market Leading Geography: Which Region Contributes The Most Revenue?#_x000D_

North America was the largest region in the leukapheresis device market in 2025. The regions covered in the leukapheresis device market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

_x000D_

#Reach Out To Our Team:#_x000D_

_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas: +1 310-496-7795_x000D_

Asia: +44 7882 955267 & +91 8897263534_x000D_

Europe: +44 7882 955267_x000D_

Email us at: marketing@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.

The leukapheresis device market is experiencing rapid growth driven by advances in medical technology and increasing demand for specialized treatments. As the prevalence of blood disorders rises and research activity expands, this market is set to evolve significantly in the coming years. Here, we explore the current market size, factors fueling expansion, key players, and emerging trends shaping the future of leukapheresis devices.

Leukapheresis Device Market Size and Projected Growth Outlook

The leukapheresis device market has seen marked growth recently, with its size expected to increase from $0.7 billion in 2025 to $0.76 billion in 2026, representing a compound annual growth rate (CAGR) of 8.6%. This expansion during the historical period has been driven by factors such as the rising incidence of leukemia and autoimmune diseases, the growing adoption of stem cell therapies, improvements in blood cell separation technologies, an increase in clinical research activities, and the expansion of hospital-based apheresis services. Moving forward, the market is forecasted to reach $1.01 billion by 2030, growing at a CAGR of 7.4%. Key contributors to this anticipated growth include heightened demand for portable leukapheresis devices, the integration of artificial intelligence and automation in equipment, growth in biopharmaceutical research, regulatory approvals for next-generation devices, and increased investment in precision medicine. Important trends expected to influence the market include the development of personalized leukapheresis treatments, minimally invasive apheresis techniques, portable and point-of-care device options, real-time monitoring system integration, and enhanced automation to improve workflow efficiency.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25807&type=smp

Rising Blood Disorders as a Major Growth Catalyst in the Leukapheresis Device Market

The increasing prevalence of blood-related disorders is a key driver supporting the leukapheresis device market’s expansion. These conditions affect blood cell function or structure, disrupting oxygen transport, immune defenses, or coagulation processes. An aging global population contributes significantly to the rise in these disorders, such as anemia, leukemia, and other hematological diseases, which predominantly affect older adults. Leukapheresis devices play a crucial role by selectively removing excess or abnormal white blood cells from the bloodstream. This helps manage symptoms and reduce complications in illnesses like leukemia and autoimmune diseases.

Highlighting this trend, the Leukaemia Foundation of Australia reported in March 2024 that about 19,500 Australians were diagnosed with blood cancers including leukemia, lymphoma, and myeloma, with nearly 43% facing substantial out-of-pocket treatment costs. Furthermore, 42% of patients took more than three months off work, underscoring both the growing incidence and the financial burdens associated with these diseases. This situation is fuelling demand for leukapheresis devices as a therapeutic solution.

Access The Complete Leukapheresis Device Market Report:

https://www.thebusinessresearchcompany.com/report/leukapheresis-device-global-market-report

Leukapheresis Device Market Segmentation by Product Types and End Users

This report breaks down the leukapheresis device market into multiple segments to provide detailed insights. By device type, the market includes therapeutic leukapheresis systems, cytapheresis devices, stem cell collection units, research application systems, leukapheresis columns and cell separators, disposables, and general apheresis devices. Components are segmented into machines, blood collection sets, medical consumables, and filters. End users consist of hospitals, academic research institutes, pharmaceutical and biotechnology companies, blood component providers, and blood centers.

Further subcategories include therapeutic leukapheresis devices for leukemia treatment, sepsis management, and autoimmune disease care. Cytapheresis covers plateletpheresis, lymphapheresis, and erythrocytapheresis systems. Stem cell collection devices include peripheral blood stem cell collectors, umbilical cord blood collection systems, and bone marrow stem cell apheresis units. Research applications feature cell separation technologies used for development and clinical trials. Leukapheresis columns and separators encompass adsorption columns, membrane-based systems, and centrifugal separators. Disposables involve tubing, needles, catheters, and collection bags. Apheresis devices include continuous flow, portable/mobile, and intermittent flow machines.

How Regional Manufacturing Efforts Are Transforming the Leukapheresis Device Market

Leading companies in the leukapheresis device field are increasingly investing in regional manufacturing capabilities to improve access to high-quality devices and support local healthcare infrastructure. Establishing production facilities closer to key markets enables more efficient supply chains, reduces reliance on imports, and lowers costs for advanced blood collection and separation technologies. For example, in November 2024, Terumo Blood and Cell Technologies partnered with its China-based subsidiary, Terumo Medical Products (Hangzhou) Co., Ltd., to launch localized manufacturing in Hangzhou. This initiative focuses on producing widely used leukapheresis devices such as the Trima Accel Automated Blood Collection System and the Spectra Optia Apheresis System, which are essential for therapeutic apheresis, stem cell collection, and blood component separation across China.

Market Competition and Key Players in the Leukapheresis Device Sector

The leukapheresis device market features competition among several prominent companies, including Fresenius SE and Co. KGaA, Asahi Kasei Medical Co. Ltd, Baxter International Inc., Grifols S.A., TERUMO BCT INC., Kaneka Corporation, Nikkiso Co. Ltd, Haemonetics Corporation, Miltenyi Biotec GmbH, Macopharma, B. Braun Melsungen AG, Kawasumi Laboratories Inc., Beijing Zksk Technology Co. Ltd, Puriblood Medical Co. Ltd, Fresenius Kabi AG, JMS Co. Ltd, HemaCare Corporation, Medica Group PLC, LivaNova PLC, Cytiva, BioSafe Group SA, and Terumo Corporation. These organizations are continually innovating and expanding their portfolios to meet evolving clinical needs.

North America Leads the Leukapheresis Device Market by Market Share

In 2025, North America held the leading position in the global leukapheresis device market. The report covers various geographic regions including Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, offering a comprehensive view of regional market dynamics and future growth opportunities.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Is The Expected Market Value Outlook For The Leukapheresis Device Market Through 2030?

The leukapheresis device market has experienced substantial growth in recent years. It is anticipated to expand from $0.7 billion in 2025 to $0.76 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 8.6%. This historical growth can be ascribed to the increasing occurrence of leukemia and autoimmune disorders, the uptake of stem cell therapies, improvements in blood cell separation technology, an increase in clinical research activities, and the development of hospital-based apheresis services.

The leukapheresis device market is projected to experience robust expansion over the coming years. This market is forecast to reach $1.01 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.4%. The anticipated growth during this period can be attributed to the rising demand for portable leukapheresis systems, the incorporation of ai and automation into devices, the expansion of biopharmaceutical research, the granting of regulatory approvals for advanced apheresis devices, and increasing investments in precision medicine. Significant trends in the forecast period include the development of personalized leukapheresis treatments, the adoption of minimally invasive apheresis techniques, the availability of portable and point-of-care leukapheresis devices, the integration of real-time monitoring systems, and enhanced automation and workflow efficiency.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25807&type=smp

Which Significant Factors Are Encouraging Growth In The Leukapheresis Device Market?

An anticipated increase in blood-related disorders is set to boost the expansion of the leukapheresis device market in the coming years. These disorders involve conditions that affect the structural integrity or functional capability of blood cells, leading to issues with oxygen transport, the body’s immune defense, or blood coagulation. The growing occurrence of such conditions is predominantly linked to an aging global population, given that older individuals exhibit higher susceptibility to ailments like anemia, leukemia, and other hematological issues. Leukapheresis devices play a role in managing these conditions by facilitating the targeted removal of surplus or atypical white blood cells from the circulation, which in turn helps to ease symptoms and diminish complications in diseases like leukemia and various autoimmune disorders. For example, in March 2024, the Leukaemia Foundation, an Australia-based non-profit organization, reported that approximately 19,500 Australians received a diagnosis of blood cancer, encompassing leukemia, lymphoma, and myeloma. Notably, nearly 43% faced significant out-of-pocket treatment costs, and 42% were absent from work for more than three months, which underscores both the increasing incidence and the financial burden on patients and their families compared to previous years. Consequently, the increasing prevalence of blood-related disorders is indeed fueling the expansion of the leukapheresis device market.

What Segment Types Are Included In The Leukapheresis Device Market Analysis?

The leukapheresis device market covered in this report is segmented –

1) By Device Type: Therapeutic Leukapheresis, Cytapheresis, Stem Cell Collection, Research Applications, Leukapheresis Columns and Cell Separators, Leukapheresis Disposables, Apheresis Devices

2) By Component: Leukapheresis Machine, Blood Collection Set , Medical Consumables , Filters

3) By End User: Hospitals, Academic Research Institutes, Pharmaceutical And Biotechnology Companies, Blood Component Providers, Blood Centers

Subsegments:

1) By Therapeutic Leukapheresis: Leukemia Treatment Systems, Sepsis Treatment Leukapheresis Units, Autoimmune Disease Management Devices

2) By Cytapheresis: Plateletpheresis Devices, Lymphapheresis Units, Erythrocytapheresis Systems

3) By Stem Cell Collection: Peripheral Blood Stem Cell (PBSC) Collection Devices, Umbilical Cord Blood Collection Systems, Bone Marrow Stem Cell Apheresis Systems

4) By Research Applications: Cell Separation Systems for Research and Development, Clinical Trial Apheresis Platforms, Academic Laboratory Leukapheresis Devices

5) By Leukapheresis Columns And Cell Separators: Adsorption Columns, Membrane-Based Cell Separation Systems, Centrifugal Cell Separators

6) By Leukapheresis Disposables: Tubing Sets, Needles And Catheters, Collection Bags

7) By Apheresis Devices: Continuous Flow Apheresis Machines, Portable Or Mobile Apheresis Units, Intermittent Flow Apheresis Systems

Which Trends Are Guiding The Development Of The Leukapheresis Device Market?

Leading companies operating within the leukapheresis device market are prioritizing investments in establishing regional manufacturing capabilities. This focus aims to enhance the availability of premium therapeutic devices locally and to further national healthcare objectives. Such regional production endeavors foster streamlined and adaptable supply chains, which in turn guarantee prompt product delivery, lessen reliance on imported goods, and make advanced blood and cell collection systems more economically accessible. A notable example occurred in November 2024, when Terumo Blood and Cell Technologies, a medical technology firm based in the US, collaborated with its China-based medical technology subsidiary, Terumo Medical Products (Hangzhou) Co., Ltd., to commence local production activities in Hangzhou, China. This calculated initiative involves the domestic creation of key leukapheresis items, including the Trima Accel Automated Blood Collection System and the Spectra Optia Apheresis System, both of which are extensively utilized throughout China for therapeutic apheresis, stem cell collection, and the separation of blood components.

Who Are The Key Market Participants In The Leukapheresis Device Market?

Major companies operating in the leukapheresis device market are Fresenius SE and Co. KGaA, Asahi Kasei Medical Co. Ltd, Baxter International Inc., Grifols S.A., TERUMO BCT INC., Kaneka Corporation, Nikkiso Co. Ltd, Haemonetics Corporation, Miltenyi Biotec GmbH, Macopharma, B. Braun Melsungen AG, Kawasumi Laboratories Inc., Beijing Zksk Technology Co. Ltd, Puriblood Medical Co. Ltd, Fresenius Kabi AG, JMS Co. Ltd, HemaCare Corporation, Medica Group PLC, LivaNova PLC, Cytiva, BioSafe Group SA, Terumo Corporation

Access The Complete Leukapheresis Device Market Report:

https://www.thebusinessresearchcompany.com/report/leukapheresis-device-global-market-report

Which Region Has The Strongest Presence In The Leukapheresis Device Market?

North America was the largest region in the leukapheresis device market in 2025. The regions covered in the leukapheresis device market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a Leukapheresis Device Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/report/leukapheresis-device-global-market-report

Browse Through More Reports Similar to the Global Leukapheresis Device Market 2026, By The Business Research Company

Interventional Oncology Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/interventional-oncology-devices-global-market-report

Nephrostomy Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/nephrostomy-devices-global-market-report

Electrical Stimulation Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/electrical-stimulation-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Is The Expected Market Value Outlook For The Leukapheresis Device Market Through 2030?

The leukapheresis device market has experienced substantial growth in recent years. It is anticipated to expand from $0.7 billion in 2025 to $0.76 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 8.6%. This historical growth can be ascribed to the increasing occurrence of leukemia and autoimmune disorders, the uptake of stem cell therapies, improvements in blood cell separation technology, an increase in clinical research activities, and the development of hospital-based apheresis services.

The leukapheresis device market is projected to experience robust expansion over the coming years. This market is forecast to reach $1.01 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.4%. The anticipated growth during this period can be attributed to the rising demand for portable leukapheresis systems, the incorporation of ai and automation into devices, the expansion of biopharmaceutical research, the granting of regulatory approvals for advanced apheresis devices, and increasing investments in precision medicine. Significant trends in the forecast period include the development of personalized leukapheresis treatments, the adoption of minimally invasive apheresis techniques, the availability of portable and point-of-care leukapheresis devices, the integration of real-time monitoring systems, and enhanced automation and workflow efficiency.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25807&type=smp

Which Significant Factors Are Encouraging Growth In The Leukapheresis Device Market?

An anticipated increase in blood-related disorders is set to boost the expansion of the leukapheresis device market in the coming years. These disorders involve conditions that affect the structural integrity or functional capability of blood cells, leading to issues with oxygen transport, the body’s immune defense, or blood coagulation. The growing occurrence of such conditions is predominantly linked to an aging global population, given that older individuals exhibit higher susceptibility to ailments like anemia, leukemia, and other hematological issues. Leukapheresis devices play a role in managing these conditions by facilitating the targeted removal of surplus or atypical white blood cells from the circulation, which in turn helps to ease symptoms and diminish complications in diseases like leukemia and various autoimmune disorders. For example, in March 2024, the Leukaemia Foundation, an Australia-based non-profit organization, reported that approximately 19,500 Australians received a diagnosis of blood cancer, encompassing leukemia, lymphoma, and myeloma. Notably, nearly 43% faced significant out-of-pocket treatment costs, and 42% were absent from work for more than three months, which underscores both the increasing incidence and the financial burden on patients and their families compared to previous years. Consequently, the increasing prevalence of blood-related disorders is indeed fueling the expansion of the leukapheresis device market.

What Segment Types Are Included In The Leukapheresis Device Market Analysis?

The leukapheresis device market covered in this report is segmented –

1) By Device Type: Therapeutic Leukapheresis, Cytapheresis, Stem Cell Collection, Research Applications, Leukapheresis Columns and Cell Separators, Leukapheresis Disposables, Apheresis Devices

2) By Component: Leukapheresis Machine, Blood Collection Set , Medical Consumables , Filters

3) By End User: Hospitals, Academic Research Institutes, Pharmaceutical And Biotechnology Companies, Blood Component Providers, Blood Centers

Subsegments:

1) By Therapeutic Leukapheresis: Leukemia Treatment Systems, Sepsis Treatment Leukapheresis Units, Autoimmune Disease Management Devices

2) By Cytapheresis: Plateletpheresis Devices, Lymphapheresis Units, Erythrocytapheresis Systems

3) By Stem Cell Collection: Peripheral Blood Stem Cell (PBSC) Collection Devices, Umbilical Cord Blood Collection Systems, Bone Marrow Stem Cell Apheresis Systems

4) By Research Applications: Cell Separation Systems for Research and Development, Clinical Trial Apheresis Platforms, Academic Laboratory Leukapheresis Devices

5) By Leukapheresis Columns And Cell Separators: Adsorption Columns, Membrane-Based Cell Separation Systems, Centrifugal Cell Separators

6) By Leukapheresis Disposables: Tubing Sets, Needles And Catheters, Collection Bags

7) By Apheresis Devices: Continuous Flow Apheresis Machines, Portable Or Mobile Apheresis Units, Intermittent Flow Apheresis Systems

Which Trends Are Guiding The Development Of The Leukapheresis Device Market?

Leading companies operating within the leukapheresis device market are prioritizing investments in establishing regional manufacturing capabilities. This focus aims to enhance the availability of premium therapeutic devices locally and to further national healthcare objectives. Such regional production endeavors foster streamlined and adaptable supply chains, which in turn guarantee prompt product delivery, lessen reliance on imported goods, and make advanced blood and cell collection systems more economically accessible. A notable example occurred in November 2024, when Terumo Blood and Cell Technologies, a medical technology firm based in the US, collaborated with its China-based medical technology subsidiary, Terumo Medical Products (Hangzhou) Co., Ltd., to commence local production activities in Hangzhou, China. This calculated initiative involves the domestic creation of key leukapheresis items, including the Trima Accel Automated Blood Collection System and the Spectra Optia Apheresis System, both of which are extensively utilized throughout China for therapeutic apheresis, stem cell collection, and the separation of blood components.

Who Are The Key Market Participants In The Leukapheresis Device Market?

Major companies operating in the leukapheresis device market are Fresenius SE and Co. KGaA, Asahi Kasei Medical Co. Ltd, Baxter International Inc., Grifols S.A., TERUMO BCT INC., Kaneka Corporation, Nikkiso Co. Ltd, Haemonetics Corporation, Miltenyi Biotec GmbH, Macopharma, B. Braun Melsungen AG, Kawasumi Laboratories Inc., Beijing Zksk Technology Co. Ltd, Puriblood Medical Co. Ltd, Fresenius Kabi AG, JMS Co. Ltd, HemaCare Corporation, Medica Group PLC, LivaNova PLC, Cytiva, BioSafe Group SA, Terumo Corporation

Access The Complete Leukapheresis Device Market Report:

https://www.thebusinessresearchcompany.com/report/leukapheresis-device-global-market-report

Which Region Has The Strongest Presence In The Leukapheresis Device Market?

North America was the largest region in the leukapheresis device market in 2025. The regions covered in the leukapheresis device market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a Leukapheresis Device Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/report/leukapheresis-device-global-market-report

Browse Through More Reports Similar to the Global Leukapheresis Device Market 2026, By The Business Research Company

Interventional Oncology Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/interventional-oncology-devices-global-market-report

Nephrostomy Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/nephrostomy-devices-global-market-report

Electrical Stimulation Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/electrical-stimulation-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Is The Expected Market Value Outlook For The Leukapheresis Device Market Through 2030?

The leukapheresis device market has experienced substantial growth in recent years. It is anticipated to expand from $0.7 billion in 2025 to $0.76 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 8.6%. This historical growth can be ascribed to the increasing occurrence of leukemia and autoimmune disorders, the uptake of stem cell therapies, improvements in blood cell separation technology, an increase in clinical research activities, and the development of hospital-based apheresis services.

The leukapheresis device market is projected to experience robust expansion over the coming years. This market is forecast to reach $1.01 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.4%. The anticipated growth during this period can be attributed to the rising demand for portable leukapheresis systems, the incorporation of ai and automation into devices, the expansion of biopharmaceutical research, the granting of regulatory approvals for advanced apheresis devices, and increasing investments in precision medicine. Significant trends in the forecast period include the development of personalized leukapheresis treatments, the adoption of minimally invasive apheresis techniques, the availability of portable and point-of-care leukapheresis devices, the integration of real-time monitoring systems, and enhanced automation and workflow efficiency.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25807&type=smp

Which Significant Factors Are Encouraging Growth In The Leukapheresis Device Market?

An anticipated increase in blood-related disorders is set to boost the expansion of the leukapheresis device market in the coming years. These disorders involve conditions that affect the structural integrity or functional capability of blood cells, leading to issues with oxygen transport, the body’s immune defense, or blood coagulation. The growing occurrence of such conditions is predominantly linked to an aging global population, given that older individuals exhibit higher susceptibility to ailments like anemia, leukemia, and other hematological issues. Leukapheresis devices play a role in managing these conditions by facilitating the targeted removal of surplus or atypical white blood cells from the circulation, which in turn helps to ease symptoms and diminish complications in diseases like leukemia and various autoimmune disorders. For example, in March 2024, the Leukaemia Foundation, an Australia-based non-profit organization, reported that approximately 19,500 Australians received a diagnosis of blood cancer, encompassing leukemia, lymphoma, and myeloma. Notably, nearly 43% faced significant out-of-pocket treatment costs, and 42% were absent from work for more than three months, which underscores both the increasing incidence and the financial burden on patients and their families compared to previous years. Consequently, the increasing prevalence of blood-related disorders is indeed fueling the expansion of the leukapheresis device market.

What Segment Types Are Included In The Leukapheresis Device Market Analysis?

The leukapheresis device market covered in this report is segmented –

1) By Device Type: Therapeutic Leukapheresis, Cytapheresis, Stem Cell Collection, Research Applications, Leukapheresis Columns and Cell Separators, Leukapheresis Disposables, Apheresis Devices

2) By Component: Leukapheresis Machine, Blood Collection Set , Medical Consumables , Filters

3) By End User: Hospitals, Academic Research Institutes, Pharmaceutical And Biotechnology Companies, Blood Component Providers, Blood Centers

Subsegments:

1) By Therapeutic Leukapheresis: Leukemia Treatment Systems, Sepsis Treatment Leukapheresis Units, Autoimmune Disease Management Devices

2) By Cytapheresis: Plateletpheresis Devices, Lymphapheresis Units, Erythrocytapheresis Systems

3) By Stem Cell Collection: Peripheral Blood Stem Cell (PBSC) Collection Devices, Umbilical Cord Blood Collection Systems, Bone Marrow Stem Cell Apheresis Systems

4) By Research Applications: Cell Separation Systems for Research and Development, Clinical Trial Apheresis Platforms, Academic Laboratory Leukapheresis Devices

5) By Leukapheresis Columns And Cell Separators: Adsorption Columns, Membrane-Based Cell Separation Systems, Centrifugal Cell Separators

6) By Leukapheresis Disposables: Tubing Sets, Needles And Catheters, Collection Bags

7) By Apheresis Devices: Continuous Flow Apheresis Machines, Portable Or Mobile Apheresis Units, Intermittent Flow Apheresis Systems

Which Trends Are Guiding The Development Of The Leukapheresis Device Market?

Leading companies operating within the leukapheresis device market are prioritizing investments in establishing regional manufacturing capabilities. This focus aims to enhance the availability of premium therapeutic devices locally and to further national healthcare objectives. Such regional production endeavors foster streamlined and adaptable supply chains, which in turn guarantee prompt product delivery, lessen reliance on imported goods, and make advanced blood and cell collection systems more economically accessible. A notable example occurred in November 2024, when Terumo Blood and Cell Technologies, a medical technology firm based in the US, collaborated with its China-based medical technology subsidiary, Terumo Medical Products (Hangzhou) Co., Ltd., to commence local production activities in Hangzhou, China. This calculated initiative involves the domestic creation of key leukapheresis items, including the Trima Accel Automated Blood Collection System and the Spectra Optia Apheresis System, both of which are extensively utilized throughout China for therapeutic apheresis, stem cell collection, and the separation of blood components.

Who Are The Key Market Participants In The Leukapheresis Device Market?

Major companies operating in the leukapheresis device market are Fresenius SE and Co. KGaA, Asahi Kasei Medical Co. Ltd, Baxter International Inc., Grifols S.A., TERUMO BCT INC., Kaneka Corporation, Nikkiso Co. Ltd, Haemonetics Corporation, Miltenyi Biotec GmbH, Macopharma, B. Braun Melsungen AG, Kawasumi Laboratories Inc., Beijing Zksk Technology Co. Ltd, Puriblood Medical Co. Ltd, Fresenius Kabi AG, JMS Co. Ltd, HemaCare Corporation, Medica Group PLC, LivaNova PLC, Cytiva, BioSafe Group SA, Terumo Corporation

Access The Complete Leukapheresis Device Market Report:

https://www.thebusinessresearchcompany.com/report/leukapheresis-device-global-market-report

Which Region Has The Strongest Presence In The Leukapheresis Device Market?

North America was the largest region in the leukapheresis device market in 2025. The regions covered in the leukapheresis device market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a Leukapheresis Device Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/report/leukapheresis-device-global-market-report

Browse Through More Reports Similar to the Global Leukapheresis Device Market 2026, By The Business Research Company

Interventional Oncology Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/interventional-oncology-devices-global-market-report

Nephrostomy Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/nephrostomy-devices-global-market-report

Electrical Stimulation Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/electrical-stimulation-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Will The Market Value Of The Leukapheresis Device Market Progress Between 2026 And 2030?

The leukapheresis device market size has witnessed significant expansion in recent years. Projections indicate it will expand from $0.7 billion in 2025 to $0.76 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.6%. This growth observed historically can be attributed to several factors including the rising prevalence of leukemia and autoimmune disorders, the increasing adoption of stem cell therapies, continuous advancements in blood cell separation technology, a surge in clinical research activities, and the expansion of hospital-based apheresis services.

The leukapheresis device market is anticipated to experience substantial expansion in the coming years. This market is projected to reach $1.01 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.4%. This anticipated growth is driven by several factors, including the increasing demand for portable leukapheresis systems, the incorporation of AI and automation into these devices, the ongoing expansion of biopharmaceutical research, the granting of regulatory approvals for advanced apheresis devices, and a rise in investments directed towards precision medicine. Key trends characterizing this forecast period encompass personalized leukapheresis treatments, the adoption of minimally invasive apheresis techniques, the development of portable and point-of-care leukapheresis devices, the integration of real-time monitoring systems, and advancements in automation and workflow efficiency.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/leukapheresis-device-global-market-report

What Significant Factors Are Influencing The Leukapheresis Device Market Expansion?

The increasing occurrence of blood-related disorders is anticipated to fuel the expansion of the leukapheresis device market. Blood-related disorders are medical conditions that impact the structure or functionality of blood cells, leading to complications in oxygen delivery, immune responses, or blood clotting. The growing incidence of these disorders is mainly linked to an aging population, as older individuals are more vulnerable to conditions such as anemia, leukemia, and various hematological issues. Leukapheresis devices play a crucial role in managing these conditions by selectively extracting surplus or abnormal white blood cells from the bloodstream, thereby helping to mitigate symptoms and minimize complications in diseases like leukemia and autoimmune conditions. For example, in March 2024, the Leukaemia Foundation, an Australia-based non-profit organization, reported that around 19,500 Australians were diagnosed with blood cancer, including leukemia, lymphoma, and myeloma, with nearly 43% incurring significant out-of-pocket treatment costs and 42% requiring over three months off work, emphasizing both the rising incidence and the financial burden on patients and their families compared to previous years. Consequently, the rising prevalence of blood-related disorders is driving the growth of the leukapheresis device market.

Which Segment Categories Are Included In The Leukapheresis Device Market Segment Analysis?

The leukapheresis device market covered in this report is segmented –

1) By Device Type: Therapeutic Leukapheresis, Cytapheresis, Stem Cell Collection, Research Applications, Leukapheresis Columns and Cell Separators, Leukapheresis Disposables, Apheresis Devices

2) By Component: Leukapheresis Machine, Blood Collection Set , Medical Consumables , Filters

3) By End User: Hospitals, Academic Research Institutes, Pharmaceutical And Biotechnology Companies, Blood Component Providers, Blood Centers

Subsegments:

1) By Therapeutic Leukapheresis: Leukemia Treatment Systems, Sepsis Treatment Leukapheresis Units, Autoimmune Disease Management Devices

2) By Cytapheresis: Plateletpheresis Devices, Lymphapheresis Units, Erythrocytapheresis Systems

3) By Stem Cell Collection: Peripheral Blood Stem Cell (PBSC) Collection Devices, Umbilical Cord Blood Collection Systems, Bone Marrow Stem Cell Apheresis Systems

4) By Research Applications: Cell Separation Systems for Research and Development, Clinical Trial Apheresis Platforms, Academic Laboratory Leukapheresis Devices

5) By Leukapheresis Columns And Cell Separators: Adsorption Columns, Membrane-Based Cell Separation Systems, Centrifugal Cell Separators

6) By Leukapheresis Disposables: Tubing Sets, Needles And Catheters, Collection Bags

7) By Apheresis Devices: Continuous Flow Apheresis Machines, Portable Or Mobile Apheresis Units, Intermittent Flow Apheresis Systems

What Trends Are Affecting The Direction Of The Leukapheresis Device Market?

Key companies operating in the leukapheresis device market are prioritizing investments in regional manufacturing to enhance local accessibility to high-quality therapeutic devices and support national healthcare agendas. These regional production commitments contribute to establishing efficient and flexible supply chains, ensuring timely product delivery, reducing dependence on imports, and improving the affordability of advanced blood and cell collection systems. For instance, in November 2024, Terumo Blood and Cell Technologies, a US-based medical technology company, partnered with Terumo Medical Products (Hangzhou) Co., Ltd., a China-based medical technology subsidiary company, to commence localized production in Hangzhou, China. This strategic initiative encompasses the domestic manufacturing of critical leukapheresis products, including the Trima Accel Automated Blood Collection System and the Spectra Optia Apheresis System, both of which are widely employed in China for therapeutic apheresis, stem cell collection, and blood component separation.

Who Are The Active Companies Shaping The Leukapheresis Device Market?

Major companies operating in the leukapheresis device market are Fresenius SE and Co. KGaA, Asahi Kasei Medical Co. Ltd, Baxter International Inc., Grifols S.A., TERUMO BCT INC., Kaneka Corporation, Nikkiso Co. Ltd, Haemonetics Corporation, Miltenyi Biotec GmbH, Macopharma, B. Braun Melsungen AG, Kawasumi Laboratories Inc., Beijing Zksk Technology Co. Ltd, Puriblood Medical Co. Ltd, Fresenius Kabi AG, JMS Co. Ltd, HemaCare Corporation, Medica Group PLC, LivaNova PLC, Cytiva, BioSafe Group SA, Terumo Corporation

Get The Full Leukapheresis Device Market Report:

https://www.thebusinessresearchcompany.com/report/leukapheresis-device-global-market-report

Which Region Is The Leading Market For The Leukapheresis Device Market?

North America was the largest region in the leukapheresis device market in 2025. The regions covered in the leukapheresis device market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Leukapheresis Device Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/leukapheresis-device-global-market-report

Browse Through More Reports Similar to the Global Leukapheresis Device Market 2026, By The Business Research Company

Interventional Oncology Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/interventional-oncology-devices-global-market-report

Nephrostomy Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/nephrostomy-devices-global-market-report

Electrical Stimulation Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/electrical-stimulation-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Estimated Market Size Of The Leukapheresis Device Market During 2026–2030?

The leukapheresis device market has experienced substantial expansion in its size over recent years. Its projected growth trajectory indicates an increase from $0.7 billion in 2025 to $0.76 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 8.6%. Historically, this market’s expansion was driven by factors such as the increasing incidence of leukemia and autoimmune conditions, the wider acceptance of stem cell therapies, innovations in blood cell separation technology, a surge in clinical research endeavors, and the development of hospital-based apheresis services.

The leukapheresis device market size is projected to experience robust expansion over the coming years. This market is predicted to reach $1.01 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 7.4%. This growth during the forecast period is attributable to several factors, including the increasing demand for portable leukapheresis systems, the incorporation of AI and automation into devices, the broadening scope of biopharmaceutical research, regulatory endorsements for advanced apheresis devices, and heightened investments in precision medicine. Key trends anticipated in the forecast period encompass personalized leukapheresis treatments, the adoption of minimally invasive apheresis techniques, the development of portable and point-of-care leukapheresis devices, the embedding of real-time monitoring systems, and improvements in automation and workflow efficiency.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25807&type=smp

What Underlying Factors Are Accelerating The Growth Of The Leukapheresis Device Market?

An anticipated increase in the incidence of blood-related conditions is set to fuel the expansion of the leukapheresis device market in the coming years. These disorders are characterized by disruptions in the formation or operation of blood cells, leading to complications in oxygen transport, immune system function, or blood coagulation. The growing occurrence of these conditions is largely linked to an aging demographic, given that elderly people are more prone to illnesses like anemia, leukemia, and other hematological ailments. Leukapheresis devices play a crucial role in treating such disorders by methodically removing surplus or atypical white blood cells from the circulatory system, which aids in mitigating symptoms and minimizing complications in diseases like leukemia and various autoimmune conditions. For example, data from March 2024, released by the Leukaemia Foundation, an Australia-based non-profit organization, indicated that approximately 19,500 Australians received a diagnosis of blood cancer, encompassing leukemia, lymphoma, and myeloma. This data further showed that almost 43% incurred substantial out-of-pocket treatment expenses and 42% took more than three months away from work, underscoring both the increasing frequency and the economic strain on patients and their households compared to prior years. Consequently, the increasing occurrence of blood-related disorders is propelling the expansion of the leukapheresis device market.

How Are The Various Segments Of The Leukapheresis Device Market Categorized?

The leukapheresis device market covered in this report is segmented –

1) By Device Type: Therapeutic Leukapheresis, Cytapheresis, Stem Cell Collection, Research Applications, Leukapheresis Columns and Cell Separators, Leukapheresis Disposables, Apheresis Devices

2) By Component: Leukapheresis Machine, Blood Collection Set , Medical Consumables , Filters

3) By End User: Hospitals, Academic Research Institutes, Pharmaceutical And Biotechnology Companies, Blood Component Providers, Blood Centers

Subsegments:

1) By Therapeutic Leukapheresis: Leukemia Treatment Systems, Sepsis Treatment Leukapheresis Units, Autoimmune Disease Management Devices

2) By Cytapheresis: Plateletpheresis Devices, Lymphapheresis Units, Erythrocytapheresis Systems

3) By Stem Cell Collection: Peripheral Blood Stem Cell (PBSC) Collection Devices, Umbilical Cord Blood Collection Systems, Bone Marrow Stem Cell Apheresis Systems

4) By Research Applications: Cell Separation Systems for Research and Development, Clinical Trial Apheresis Platforms, Academic Laboratory Leukapheresis Devices

5) By Leukapheresis Columns And Cell Separators: Adsorption Columns, Membrane-Based Cell Separation Systems, Centrifugal Cell Separators

6) By Leukapheresis Disposables: Tubing Sets, Needles And Catheters, Collection Bags

7) By Apheresis Devices: Continuous Flow Apheresis Machines, Portable Or Mobile Apheresis Units, Intermittent Flow Apheresis Systems

What Trends Are Affecting The Expansion Of The Leukapheresis Device Market?

Leading entities within the leukapheresis device sector are prioritizing investments in localized production facilities, with the aim of boosting local availability of superior therapeutic devices and furthering national health objectives. These commitments to regional manufacturing contribute to the establishment of agile and effective supply chains, guaranteeing prompt delivery, lessening reliance on imported goods, and making advanced blood and cell collection systems more economical. An illustrative example occurred in November 2024, when Terumo Blood and Cell Technologies, a medical technology firm based in the US, collaborated with its Chinese medical technology subsidiary, Terumo Medical Products (Hangzhou) Co., Ltd., to initiate local production operations in Hangzhou, China. This strategic initiative entails the domestic production of essential leukapheresis items such as the Trima Accel Automated Blood Collection System and the Spectra Optia Apheresis System, which are extensively utilized across China for purposes like therapeutic apheresis, stem cell harvesting, and the division of blood components.

Which Major Firms Influence Developments In The Leukapheresis Device Market?

Major companies operating in the leukapheresis device market are Fresenius SE and Co. KGaA, Asahi Kasei Medical Co. Ltd, Baxter International Inc., Grifols S.A., TERUMO BCT INC., Kaneka Corporation, Nikkiso Co. Ltd, Haemonetics Corporation, Miltenyi Biotec GmbH, Macopharma, B. Braun Melsungen AG, Kawasumi Laboratories Inc., Beijing Zksk Technology Co. Ltd, Puriblood Medical Co. Ltd, Fresenius Kabi AG, JMS Co. Ltd, HemaCare Corporation, Medica Group PLC, LivaNova PLC, Cytiva, BioSafe Group SA, Terumo Corporation

Read the full leukapheresis device market report here:

https://www.thebusinessresearchcompany.com/report/leukapheresis-device-global-market-report

Which Region Is Projected To Dominate The Leukapheresis Device Market During The Forecast Period?

North America was the largest region in the leukapheresis device market in 2025. The regions covered in the leukapheresis device market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Leukapheresis Device Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=25807&type=smp

Browse Through More Reports Similar to the Global Leukapheresis Device Market 2026, By The Business Research Company

Interventional Oncology Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/interventional-oncology-devices-global-market-report

Nephrostomy Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/nephrostomy-devices-global-market-report

Electrical Stimulation Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/electrical-stimulation-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the worker heat stress monitoring wearable market from 2026–2035 with trusted insights from The Business Research Company

What growth pattern is forecast for the Leukapheresis Device Market size between 2026 and 2035?

The leukapheresis device market has experienced significant growth over the past few years. This market is projected to expand from $0.7 billion in 2025 to $0.76 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 8.6%. Key drivers for historical market growth include an increase in the prevalence of leukemia and autoimmune disorders, the uptake of stem cell therapies, improvements in blood cell separation technology, more extensive clinical research activities, and the development of hospital-based apheresis services.

The leukapheresis device market is projected to experience robust expansion over the coming years. This market is anticipated to reach $1.01 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.4%. Several factors are contributing to this growth during the forecast period, including an increased demand for portable leukapheresis systems, the incorporation of AI and automation into these devices, the ongoing expansion of biopharmaceutical research, the approval of advanced apheresis devices by regulatory bodies, and growing investments in precision medicine. Key trends expected during this period involve personalized leukapheresis treatments, the development of minimally invasive apheresis techniques, the adoption of portable and point-of-care leukapheresis devices, the integration of real-time monitoring systems, and improvements in automation and workflow efficiency.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25807&type=smp

Which Drivers Are Impacting Market Performance In The Leukapheresis Device Market?

The increasing occurrence of blood-related conditions is projected to boost the expansion of the leukapheresis device market in the future. These disorders involve issues affecting the form or operation of blood cells, leading to difficulties in oxygen transportation, immune system function, or coagulation. The growing frequency of blood-related illnesses is largely due to an older demographic, given that elderly people are more prone to ailments like anemia, leukemia, and other hematological conditions. Leukapheresis devices aid in addressing these conditions by precisely removing surplus or abnormal white blood cells from circulation, which helps ease symptoms and lessen complications in illnesses like leukemia and autoimmune diseases. As an illustration, in March 2024, the Leukaemia Foundation, a non-profit organization based in Australia, reported that approximately 19,500 Australians received a diagnosis of blood cancer, encompassing leukemia, lymphoma, and myeloma. Of these, nearly 43% incurred substantial out-of-pocket treatment expenses, and 42% took more than three months away from work, underscoring both the increasing occurrence and the financial strain on patients and their relatives relative to prior years. Consequently, the increasing occurrence of blood-related disorders is fueling the expansion of the leukapheresis device market.

Which Segments Are Contributing To The Growth Of The Leukapheresis Device Market?

The leukapheresis device market covered in this report is segmented –

1) By Device Type: Therapeutic Leukapheresis, Cytapheresis, Stem Cell Collection, Research Applications, Leukapheresis Columns and Cell Separators, Leukapheresis Disposables, Apheresis Devices

2) By Component: Leukapheresis Machine, Blood Collection Set , Medical Consumables , Filters

3) By End User: Hospitals, Academic Research Institutes, Pharmaceutical And Biotechnology Companies, Blood Component Providers, Blood Centers

Subsegments:

1) By Therapeutic Leukapheresis: Leukemia Treatment Systems, Sepsis Treatment Leukapheresis Units, Autoimmune Disease Management Devices

2) By Cytapheresis: Plateletpheresis Devices, Lymphapheresis Units, Erythrocytapheresis Systems

3) By Stem Cell Collection: Peripheral Blood Stem Cell (PBSC) Collection Devices, Umbilical Cord Blood Collection Systems, Bone Marrow Stem Cell Apheresis Systems

4) By Research Applications: Cell Separation Systems for Research and Development, Clinical Trial Apheresis Platforms, Academic Laboratory Leukapheresis Devices

5) By Leukapheresis Columns And Cell Separators: Adsorption Columns, Membrane-Based Cell Separation Systems, Centrifugal Cell Separators

6) By Leukapheresis Disposables: Tubing Sets, Needles And Catheters, Collection Bags

7) By Apheresis Devices: Continuous Flow Apheresis Machines, Portable Or Mobile Apheresis Units, Intermittent Flow Apheresis Systems

Which Trends Are Influencing The Performance And Direction Of The Leukapheresis Device Market?

Major enterprises operating within the leukapheresis device market are increasingly focused on investing in regional manufacturing capabilities. This strategy aims to enhance local access to high-quality therapeutic devices and support national healthcare goals. Such regional manufacturing investments contribute to the creation of efficient and flexible supply chains, which in turn ensure timely delivery, reduce dependency on imports, and improve the affordability of advanced blood and cell collection systems. For instance, in November 2024, Terumo Blood and Cell Technologies, a US-based medical technology company, collaborated with Terumo Medical Products (Hangzhou) Co., Ltd., a China-based medical technology subsidiary, to initiate localized production in Hangzhou, China. This strategic move involves the domestic manufacturing of key leukapheresis products, including the Trima Accel Automated Blood Collection System and the Spectra Optia Apheresis System, both of which are widely utilized in China for therapeutic apheresis, stem cell collection, and blood component separation.

Who Are The Prominent Global Companies Shaping The Leukapheresis Device Market Landscape?

Major companies operating in the leukapheresis device market are Fresenius SE and Co. KGaA, Asahi Kasei Medical Co. Ltd, Baxter International Inc., Grifols S.A., TERUMO BCT INC., Kaneka Corporation, Nikkiso Co. Ltd, Haemonetics Corporation, Miltenyi Biotec GmbH, Macopharma, B. Braun Melsungen AG, Kawasumi Laboratories Inc., Beijing Zksk Technology Co. Ltd, Puriblood Medical Co. Ltd, Fresenius Kabi AG, JMS Co. Ltd, HemaCare Corporation, Medica Group PLC, LivaNova PLC, Cytiva, BioSafe Group SA, Terumo Corporation

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/leukapheresis-device-global-market-report

Which Region Currently Holds The Largest Share Of The Leukapheresis Device Market?

North America was the largest region in the leukapheresis device market in 2025. The regions covered in the leukapheresis device market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Leukapheresis Device Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=25807&type=smp

Browse Through More Reports Similar to the Global Leukapheresis Device Market 2026, By The Business Research Company

Interventional Oncology Devices Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/interventional-oncology-devices-global-market-report

Nephrostomy Devices Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/nephrostomy-devices-global-market-report

Electrical Stimulation Devices Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/electrical-stimulation-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Future Market Size Estimation For The Leukapheresis Device Market Covering 2025–2034?

The leukapheresis device market has experienced significant expansion recently. It is projected to increase from $0.65 billion in 2024 to $0.70 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 7.7%. The market’s past growth can be ascribed to factors such as the burgeoning demand for personalized medicine, a stronger focus on research and development, a rising volume of clinical trials, the expanding geriatric population, and the growing adoption of minimally invasive procedures.

The leukapheresis device market is set for significant expansion in the coming years. It is forecast to climb to $0.94 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 7.5%. This growth projection for the forecast period is fueled by several factors, including the rising incidence of blood-related disorders, an increasing number of cancer cases, a growing necessity for peripheral blood stem cell collection, the expanding application of leukapheresis in cellular therapies, and elevated investments in regenerative medicine and immunotherapy. Noteworthy trends during this period are expected to include technological progress in apheresis devices, the incorporation of automation and digital interfaces, advancements in point-of-care leukapheresis technology, improvements in closed-loop leukapheresis systems, and efficiency enhancements in cell separation driven by technology.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25807&type=smp

Which Drivers Are Shaping The Leukapheresis Device Industry’s Market Share?

The increasing occurrence of blood-related conditions is anticipated to fuel the expansion of the leukapheresis device market moving forward. These disorders involve issues affecting the structure or function of blood cells, leading to difficulties with oxygen transport, immune responses, or blood coagulation. The growing number of blood-related illnesses is mainly linked to an aging population, as older individuals face a higher risk of developing conditions like anemia, leukemia, and various hematological problems. Leukapheresis devices aid in managing these ailments by specifically removing excess or abnormal white blood cells from the bloodstream, thus helping to ease symptoms and lessen complications in diseases such as leukemia and autoimmune conditions. For example, in May 2024, data from the Leukaemia Foundation, an Australia-based non-profit organization, indicated that in 2022, approximately 19,403 Australians received diagnoses for blood cancers, including leukemia, lymphoma, or myeloma, averaging 53 cases daily, or one every 27 minutes. Currently, close to 135,000 Australians are living with a blood cancer or blood disorder, a figure expected to exceed 275,000 by 2035. Consequently, the increasing occurrence of blood-related disorders is propelling the expansion of the leukapheresis device market.

What Are The Leading Segments Analyzed In The Leukapheresis Device Market?

The leukapheresis device market covered in this report is segmented –

1) By Device Type: Therapeutic Leukapheresis, Cytapheresis, Stem Cell Collection, Research Applications, Leukapheresis Columns and Cell Separators, Leukapheresis Disposables, Apheresis Devices

2) By Component: Leukapheresis Machine, Blood Collection Set , Medical Consumables , Filters

3) By End User: Hospitals, Academic Research Institutes, Pharmaceutical And Biotechnology Companies, Blood Component Providers, Blood Centers

Subsegments:

1) By Therapeutic Leukapheresis: Leukemia Treatment Systems, Sepsis Treatment Leukapheresis Units, Autoimmune Disease Management Devices

2) By Cytapheresis: Plateletpheresis Devices, Lymphapheresis Units, Erythrocytapheresis Systems

3) By Stem Cell Collection: Peripheral Blood Stem Cell (PBSC) Collection Devices, Umbilical Cord Blood Collection Systems, Bone Marrow Stem Cell Apheresis Systems

4) By Research Applications: Cell Separation Systems for Research and Development, Clinical Trial Apheresis Platforms, Academic Laboratory Leukapheresis Devices

5) By Leukapheresis Columns And Cell Separators: Adsorption Columns, Membrane-Based Cell Separation Systems, Centrifugal Cell Separators

6) By Leukapheresis Disposables: Tubing Sets, Needles And Catheters, Collection Bags

7) By Apheresis Devices: Continuous Flow Apheresis Machines, Portable Or Mobile Apheresis Units, Intermittent Flow Apheresis Systems

How Are Emerging Market Trends Shaping The Leukapheresis Device Industry Landscape?

Major companies engaged in the leukapheresis device market are concentrating on developing regional manufacturing infrastructure to improve local access to advanced therapeutic devices and support country-specific healthcare goals. These regional manufacturing investments aid in establishing robust and flexible supply chains, which ensures timely product availability, reduces reliance on foreign imports, and makes sophisticated blood and cell collection systems more accessible financially. As an illustration, in November 2024, Terumo Blood and Cell Technologies, a US-based medical technology firm, joined forces with its Chinese medical technology subsidiary, Terumo Medical Products (Hangzhou) Co., Ltd., to inaugurate localized manufacturing operations in Hangzhou, China. This key strategic action involves the domestic production of essential leukapheresis products such as the Trima Accel Automated Blood Collection System and the Spectra Optia Apheresis System, both of which are widely employed across China for therapeutic apheresis, stem cell collection, and the separation of blood components.

Which Key Market Players Are Investing In Expansion And Innovation Of Leukapheresis Device Market?

Major companies operating in the leukapheresis device market are Fresenius SE and Co. KGaA, Asahi Kasei Medical Co. Ltd, Baxter International Inc., Grifols S.A., TERUMO BCT INC., Kaneka Corporation, Charles River Laboratories International Inc., Mallinckrodt Pharmaceuticals, Nikkiso Co. Ltd., Haemonetics Corporation, Miltenyi Biotec GmbH, Macopharma, Precision for Medicine Inc., B. Braun Melsungen AG, BioIVT LLC, AllCells LLC, Kawasumi Laboratories Inc., Beijing Zksk Technology Co. Ltd., Puriblood Medical Co. Ltd, Medica S.p.A.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/leukapheresis-device-global-market-report

Which Regional Markets Are Contributing Most To The Leukapheresis Device Industry Expansion?

North America was the largest region in the leukapheresis device market in 2024. The regions covered in the leukapheresis device market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Leukapheresis Device Market Report:

https://www.thebusinessresearchcompany.com/customise?id=25807&type=smp

Browse Through More Reports Similar to the Global Leukapheresis Device Market 2025, By The Business Research Company

Oncology Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/oncology-devices-global-market-report

Interventional Oncology Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/interventional-oncology-devices-global-market-report

Nephrostomy Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/nephrostomy-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

What Is The Current Size And Growth Outlook For The Leukapheresis Device Market?

In recent times, the leukapheresis device market has displayed substantial expansion. The market, which was valued at $0.65 billion in 2024, is set to grow to $0.70 billion in 2025, marking a compound annual growth rate (CAGR) of 7.7%. Factors contributing to the growth observed in the historic period include an increasing demand for tailored medical solutions, a heightened emphasis on research and development, a surge in clinical trials activity, an expanding aging demographic, and a growing preference for minimally invasive procedures.

In the coming years, the leukapheresis device market is poised to experience robust growth, with projections indicating a market value of $0.94 billion by 2029. This accounts for a compound annual growth rate (CAGR) of 7.5%. Factors contributing to this growth for the projected period include the increasing frequency of blood-related disorders, growth in cancer cases, the escalating need for peripheral blood stem cell collection, more prevalent usage of leukapheresis in cellular therapies, and enhanced investments in regenerative medicine and immunotherapy. The forecast period is expected to witness several trends, including advancements in apheresis devices, the incorporation of automation and digital interfaces, progression in point-of-care leukapheresis technology, development of closed-loop leukapheresis systems, and improvements in cell separation efficiency driven by technology.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25807&type=smp

What Core Drivers Are Expected To Influence The Leukapheresis Device Market?

Anticipated to be fueled by the growing occurrence of blood-related diseases, the leukapheresis device market’s expansion is on the rise. Blood-related health issues, which affect the blood cells’ structure or functionality, result in challenges with oxygen delivery, immune reaction, or blood coagulation. The surge in these health issues is mainly linked to the elderly demographic, who are more prone to conditions such as anemia, leukemia, and a variety of hematological disorders. Leukapheresis devices, by selective extraction of excessive or abnormal white blood cells from the bloodstream, aid in treating these diseases, alleviating symptoms and decreasing complications in diseases like leukemia and autoimmune conditions. As per the Leukaemia Foundation, a non-profit organization based in Australia, in May 2024, about 19,403 Australians were diagnosed with blood cancers like leukemia, lymphoma, or myeloma in 2022, averaging 53 cases daily or one every 27 minutes. Nowadays nearly 135,000 Australians are living with a blood cancer or blood disorder, a figure estimated to surpass 275,000 by 2035. Hence, the escalating prevalence of blood-related diseases is propelling the growth of the leukapheresis device market.

Which Segmentation Categories Are Highlighted In The Leukapheresis Device Market Analysis?

The leukapheresis device market covered in this report is segmented –

1) By Device Type: Therapeutic Leukapheresis, Cytapheresis, Stem Cell Collection, Research Applications, Leukapheresis Columns and Cell Separators, Leukapheresis Disposables, Apheresis Devices

2) By Component: Leukapheresis Machine, Blood Collection Set , Medical Consumables , Filters

3) By End User: Hospitals, Academic Research Institutes, Pharmaceutical And Biotechnology Companies, Blood Component Providers, Blood Centers

Subsegments:

1) By Therapeutic Leukapheresis: Leukemia Treatment Systems, Sepsis Treatment Leukapheresis Units, Autoimmune Disease Management Devices

2) By Cytapheresis: Plateletpheresis Devices, Lymphapheresis Units, Erythrocytapheresis Systems

3) By Stem Cell Collection: Peripheral Blood Stem Cell (PBSC) Collection Devices, Umbilical Cord Blood Collection Systems, Bone Marrow Stem Cell Apheresis Systems

4) By Research Applications: Cell Separation Systems for Research and Development, Clinical Trial Apheresis Platforms, Academic Laboratory Leukapheresis Devices

5) By Leukapheresis Columns And Cell Separators: Adsorption Columns, Membrane-Based Cell Separation Systems, Centrifugal Cell Separators

6) By Leukapheresis Disposables: Tubing Sets, Needles And Catheters, Collection Bags

7) By Apheresis Devices: Continuous Flow Apheresis Machines, Portable Or Mobile Apheresis Units, Intermittent Flow Apheresis Systems

Which Market Trends Are Expected To Define The Future Of The Leukapheresis Device Market?

The key players in the leukapheresis device sector are strategically investing in localized production capabilities to bolster access to superior therapeutic devices and contribute to the fulfillment of national health objectives. Investments in local production enable the formation of efficient and flexible supply chains leading to timely delivery, minimized reliance on imports, and enhanced affordability of modern blood and cell collection systems. In a recent example from November 2024, Terumo Blood and Cell Technologies, an American medical technology company, teamed up with Terumo Medical Products (Hangzhou) Co., Ltd., a medical technology subsidiary based in China, to initiate production locally in Hangzhou, China. The collaboration’s focus was to locally manufacture crucial leukapheresis products, such as the Trima Accel Automated Blood Collection System and the Spectra Optia Apheresis System, both extensively utilized in China for therapeutic apheresis, stem cell collection, and blood component separation.

Who Are The Dominant Players In The Leukapheresis Device Market Today?

Major companies operating in the leukapheresis device market are Fresenius SE and Co. KGaA, Asahi Kasei Medical Co. Ltd, Baxter International Inc., Grifols S.A., TERUMO BCT INC., Kaneka Corporation, Charles River Laboratories International Inc., Mallinckrodt Pharmaceuticals, Nikkiso Co. Ltd., Haemonetics Corporation, Miltenyi Biotec GmbH, Macopharma, Precision for Medicine Inc., B. Braun Melsungen AG, BioIVT LLC, AllCells LLC, Kawasumi Laboratories Inc., Beijing Zksk Technology Co. Ltd., Puriblood Medical Co. Ltd, Medica S.p.A.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/leukapheresis-device-global-market-report

Which Regional Markets Are Emerging As Key Hubs For The Leukapheresis Device Market?

North America was the largest region in the leukapheresis device market in 2024. The regions covered in the leukapheresis device market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=25807&type=smp

Browse Through More Reports Similar to the Global Leukapheresis Device Market 2025, By The Business Research Company

Electrical Stimulation Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/electrical-stimulation-devices-global-market-report

Cell Therapy Technologies Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cell-therapy-technologies-global-market-report

Leukemia Therapeutics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/leukemia-therapeutics-global-market-report

About The Business Research Company:

With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model